Louise Kearney | Executive Director, Rare disease, Advanced therapies and Pediatrics Team (RAPT)
Fortrea

Louise started her career in clinical research as a study coordinator at the Royal Free Hospital in 2000. Since then, she has worked as a CRA in a biotech and large Pharma in the UK and Australia before joining Fortrea 20 years ago. She spent 10 years in project management, including leading programs in rare cancers and Duchenne muscular dystrophy before moving to Fortrea’s Rare disease, Advanced Therapies and Pediatrics Team (RAPT) in 2017. Here she is taskedwith guiding study teams who work under this remit and developing best practices and successful strategies for these challenging set of studies. As part of this role she chaired Fortrea’s Cell and Gene Therapy Long-Term Follow-Up workstream, developing new models to ease patient, site and sponsor burden. Outside of Fortrea, Louise is a Trustee of Stargardt’s Connected and part of the IRDiRC’s Young Peoples Engagement Working Group.